New research has shown that an array from pill to tablet, a device to deliver antibiotics, and a drug to help treat cancer are all being tested to treat the chronic disease.
According to the National Institutes of Health, the drugs are all capable of treating certain conditions.
The results of the study, which was published Monday in the journal PLOS Medicine, show that the array of devices and treatments can all be administered via a tablet, which is also known as a “smart tablet.”
“These new findings suggest that there are potential applications for tablets for treatment of a wide range of conditions and the array that we have in this paper is quite impressive,” Dr. Robert Gebbia, a clinical scientist at the National Institute of Allergy and Infectious Diseases in Bethesda, Maryland, told NBC News.
He said that some of the treatments are likely to be used for a variety of diseases.
“The potential applications of these drugs include treating acute bacterial infections, inflammatory disorders, and chronic disease such as diabetes, cancer, and HIV/AIDS,” he said.
He added that the new array of drugs could be used to help with an array including the pill, tablet, inhaler, injectable, and nasal spray.
Gebbia said that the results of his research will help guide the development of the next generation of drugs that are being tested on people.
He explained that there’s been a growing interest in the potential use of these new drugs for treating the conditions they are supposed to treat.
“There is this notion that we don’t need to be using these drugs, that these drugs don’t work, but that they do work,” he told NBC.
“We think that they have potential, but we need to understand what the best treatment is.”
He added, “We don’t have enough information to tell us what it will do for us.”
The research team used the data to identify drugs that might be able to treat different conditions.
Dr. David Karp, a researcher at Johns Hopkins University who was not involved in the study told NBC that the data showed that a wide variety of conditions could be treated by the array.
He pointed to a recent study in which researchers showed that treating an infection with a pill was effective in preventing a new case of the disease.
The study found that a drug called diclofenac is a promising candidate to treat colitis, which affects the digestive tract.
“It is an oral antibiotic that can be used in combination with a conventional oral antibiotic such as penicillin, ampicillin, or cephalosporins, and in combination, it is a very effective drug,” he explained.
“However, it does not work as well against other strains of bacteria, so it needs to be given in conjunction with a traditional antibiotic.”
Karp said that this is one of the most promising applications of the drugs, and he expects it to be explored further in the future.
“I think we’ll be able find more new drugs that could be effective against the bacteria and we’ll see more people get better with them,” he added.